CCM
DRNA

CAAS Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

CAAS Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-489,765
Closed -$10.8M – 1085
2020
Q4 		$10.8M Buy
+489,765
New +$10.8M 0.1% 72